Pitié-Salpêtrière University Hospital is a teaching hospital in the 13th arrondissement of Paris. Part of the Assistance Publique – Hôpitaux de Paris and a teaching hospital of Sorbonne University, it is one of Europe's largest hospitals. It is also France's largest hospital.

During the past decade, Hopital Pitie Salpetriere; Hematologie Clinique conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Pitie Salpetriere; Hematologie Clinique" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Institut de cancérologie Strasbourg Europe" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Pitie Salpetriere; Hematologie Clinique" are "Chronic Lymphocytic Leukemia" (2 trials), "B-cell Lymphoma" (1 trials), "Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease" (1 trials), "Fit Patients" (1 trials) and "Intermediate Risk Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Hopital Pitie Salpetriere; Hematologie Clinique" in a lesser frequency.

Most popular intervention types in "Hopital Pitie Salpetriere; Hematologie Clinique" are "Drug" (12 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (4 trials), "CHOP" (2 trials), "Cyclophosphamide" (2 trials), "Dexamethasone" (2 trials) and "ACA Continuation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Pitie Salpetriere; Hematologie Clinique" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Pitie Salpetriere; Hematologie Clinique". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hopital Pitie Salpetriere; Hematologie Clinique, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Pitie Salpetriere; Hematologie Clinique, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".